SIA
DGX icon

Sit Investment Associates’s Quest Diagnostics DGX Stock Holding History

Sit Investment Associates’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.67M Sell
13,645
-4,970
-27% -$966K 0.05% 265
2025
Q4 		$3.23M Sell
18,615
-29,183
-61% -$5.31M 0.06% 249
2025
Q3 		$9.11M Sell
47,798
-10,045
-17% -$1.78M 0.18% 136
2025
Q2 		$10.4M Sell
57,843
-5,507
-9% -$957K 0.22% 115
2025
Q1 		$10.7M Sell
63,350
-11,804
-16% -$1.94M 0.25% 109
2024
Q4 		$11.3M Buy
75,154
+6,705
+10% +$1.04M 0.26% 104
2024
Q3 		$10.6M Sell
68,449
-6,245
-8% -$933K 0.24% 118
2024
Q2 		$10.2M Buy
74,694
+6,520
+10% +$893K 0.24% 126
2024
Q1 		$9.07M Sell
68,174
-2,530
-4% -$328K 0.21% 151
2023
Q4 		$9.75M Sell
70,704
-11,685
-14% -$1.54M 0.24% 126
2023
Q3 		$10M Buy
82,389
+12,719
+18% +$1.69M 0.28% 114
2023
Q2 		$9.79M Buy
69,670
+4,214
+6% +$581K 0.26% 114
2023
Q1 		$9.26M Buy
65,456
+16,072
+33% +$2.3M 0.25% 128
2022
Q4 		$7.73M Sell
49,384
-9,145
-16% -$1.31M 0.22% 139
2022
Q3 		$7.18M Buy
58,529
+7,400
+14% +$975K 0.21% 135
2022
Q2 		$6.8M Buy
51,129
+50,920
+24,364% +$6.94M 0.21% 139
2022
Q1 		$29K Hold
209
– – ﹤0.01% 507
2021
Q4 		$36K Buy
+209
New +$31.8K ﹤0.01% 501
2021
Q3 		– Sell
-209
Closed -$28K – 487
2021
Q2 		$28K Sell
209
-7,575
-97% -$992K ﹤0.01% 513
2021
Q1 		$999K Sell
7,784
-25,313
-76% -$3.12M 0.03% 360
2020
Q4 		$3.94M Sell
33,097
-1,653
-5% -$202K 0.11% 232
2020
Q3 		$3.98M Sell
34,750
-27,440
-44% -$3.24M 0.12% 219
2020
Q2 		$7.09M Sell
62,190
-20,160
-24% -$2.14M 0.22% 131
2020
Q1 		$6.61M Buy
82,350
+21,230
+35% +$2.2M 0.25% 115
2019
Q4 		$6.53M Sell
61,120
-41,080
-40% -$4.28M 0.19% 159
2019
Q3 		$10.9M Buy
102,200
+11,475
+13% +$1.18M 0.34% 95
2019
Q2 		$9.24M Buy
90,725
+8,325
+10% +$800K 0.28% 107
2019
Q1 		$7.41M Sell
82,400
-81,275
-50% -$7.04M 0.23% 131
2018
Q4 		$13.6M Sell
163,675
-85,400
-34% -$8.01M 0.44% 66
2018
Q3 		$26.9M Buy
249,075
+8,800
+4% +$965K 0.69% 41
2018
Q2 		$26.4M Buy
240,275
+5,728
+2% +$597K 0.68% 35
2018
Q1 		$23.5M Buy
234,547
+34,815
+17% +$3.57M 0.58% 51
2017
Q4 		$19.7M Buy
199,732
+199,710
+907,773% +$18.9M 0.47% 73
2017
Q3 		$2K Hold
22
– – ﹤0.01% 627
2017
Q2 		$2K Buy
+22
New +$2.33K ﹤0.01% 615

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Sit Investment Associates's DGX Position: Q1 2026 in Review

Sit Investment Associates reduced its Quest Diagnostics (DGX) stake by 27% in Q1 2026, selling an estimated $966K and leaving 13,645 shares worth $2.67M. The position accounts for 0.05% of the portfolio, ranked #265.

Sit Investment Associates first reported a position in DGX in Q2 2017 and has held it in 35 quarters since. The position peaked at $26.9M in Q3 2018. 1,066 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Sit Investment Associates held 13,645 shares of Quest Diagnostics worth $2.67M as of Q1 2026.
  • Sit Investment Associates sold 4,970 Quest Diagnostics shares in Q1 2026, an estimated $966K.
  • Quest Diagnostics made up 0.05% of Sit Investment Associates's portfolio in Q1 2026, its #265 holding.
  • Sit Investment Associates first reported a position in Quest Diagnostics in Q2 2017 and has held it in 35 quarters since.
  • Sit Investment Associates's Quest Diagnostics position peaked at $26.9M in Q3 2018.
  • 1,066 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Sit Investment Associates's 13F filing for Q1 2026, filed 13 May 2026.